The use of haemopoietic growth factors in blood disorders.
Open Access
- 1 December 1994
- journal article
- review article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 71 (6) , 543-547
- https://doi.org/10.1136/adc.71.6.543
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- In vitro enhancement of erythropoiesis by steel factor in diamond-blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factorThe International Journal of Cell Cloning, 1996
- Indications and guidelines for the use of hematopoietic growth factorsTransfusion, 1993
- Preliminary Results of Treatment with Filgrastim for Relapse of Leukemia and Myelodysplasia after Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1993
- Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemiasBritish Journal of Haematology, 1992
- The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietinBritish Journal of Haematology, 1991
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: A preliminary reportThe American Journal of Medicine, 1989
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Congenital agranulocytosis terminating in acute myelomonocytic leukemiaThe Journal of Pediatrics, 1979